Copyright
©The Author(s) 2022.
World J Gastroenterol. Dec 28, 2022; 28(48): 6867-6874
Published online Dec 28, 2022. doi: 10.3748/wjg.v28.i48.6867
Published online Dec 28, 2022. doi: 10.3748/wjg.v28.i48.6867
Characteristic | AIP-1 | AIP-2 |
Male/female ratio | 3/1 | 1/1 |
Mean age | 65 yr | 40 yr |
Geographical distribution | Asia > Europe and United States | Europe and United States > Asia |
Clinical presentation | Jaundice 60%-80%. Acute pancreatitis 15%. Weight loss 65% | Acute pancreatitis 80%. Jaundice < 30% |
Biological presentation | IgG4 > 1.35 g/L (sensitivity 70%, specificity 93%). IgG4 > 2.7 g/L (sensitivity 53%, specificity 99%). Lipase < 3xN. Cholestasis: > 80% of cases. Diabetes: 65% of cases. Insulin-dependent diabetes: 20% of cases. Exocrine pancreatic insufficiency: 40% of cases | Unspecific. Lipase > 3xN. Rare endocrine and exocrine pancreatic insufficiency |
Histological criteria | Lymphoplasmacytic infiltration without neutrophils. Storiform fibrosis. Obliterative venulitis. IgG4 plasma cells > 10 in a high-power field | Destruction of inter- and intralobular ducts by neutrophils (granulocytic epithelial lesions). Few or no IgG4 plasma cells |
Relapse rate after corticosteroid therapy | > 30% | < 15% |
- Citation: Mack S, Flattet Y, Bichard P, Frossard JL. Recent advances in the management of autoimmune pancreatitis in the era of artificial intelligence. World J Gastroenterol 2022; 28(48): 6867-6874
- URL: https://www.wjgnet.com/1007-9327/full/v28/i48/6867.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i48.6867